Nifty

:

24870.10

Sensex

:

81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Login

Nifty
Sensex

:
:

24870.10
81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

Rating :

70/99

BSE: 506879 | NSE: GUJTHEM

Watchlist

NSE BSE

400.60

22-Aug-2025

Open
High
Low
Previous Close

396.3
404
388.2
396.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

174125
69165418.05
405
208

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,355.34
97.66
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,372.68
0.17%
16.92

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.54
10.74
0.54

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.57
11.29
-1.34

PAT CAGR (%)

10 Years
5 Years
3 Years

26.55
10.07
-5.60

P:E (Median)

8 Years
5 Years
3 Years

16.11
20.18
47.21

P:BV (Average)

8 Years
5 Years
3 Years

9.39
9.72
11.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.09
22.22
30.42

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 5.43 4.48
P/E Ratio 73.78 89.42
Revenue 170 151
EBITDA 79 69
Net Income 59 49
ROA 30.5 18.7
P/B Ratio 21.68 17.58
ROE 33.76 21.69
FCFF -8 -21
FCFF Yield -0.23 -0.63
Net Debt -5 18
BVPS 18.48 22.79

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 35.87 38.83 -7.62% 37.74 42.01 -10.16% 39.52 38.78 1.91% 34.72 39.54 -12.19%
Expenses 21.95 20.28 8.23% 21.70 21.08 2.94% 20.65 21.11 -2.18% 19.32 22.82 -15.34%
EBITDA 13.92 18.55 -24.96% 16.04 20.93 -23.36% 18.87 17.67 6.79% 15.39 16.72 -7.95%
EBIDTM 38.81% 47.78% 42.50% 49.82% 47.74% 45.56% 44.33% 42.29%
Other Income 0.27 0.52 -48.08% 1.35 1.02 32.35% 0.24 1.08 -77.78% 0.32 1.10 -70.91%
Interest 0.04 0.07 -42.86% 0.07 0.08 -12.50% 0.14 0.08 75.00% 0.08 0.05 60.00%
Depreciation 2.03 1.15 76.52% 1.23 0.93 32.26% 1.56 0.98 59.18% 1.44 0.88 63.64%
PBT 12.12 17.86 -32.14% 16.09 20.95 -23.20% 17.40 17.69 -1.64% 14.19 16.89 -15.99%
Tax 3.06 4.62 -33.77% 4.09 5.06 -19.17% 4.43 4.68 -5.34% 3.63 4.34 -16.36%
PAT 9.06 13.24 -31.57% 12.00 15.89 -24.48% 12.97 13.01 -0.31% 10.57 12.54 -15.71%
PATM 25.26% 34.09% 31.79% 37.81% 32.82% 33.56% 30.44% 31.72%
EPS 0.83 1.21 -31.40% 1.10 1.46 -24.66% 1.19 1.19 0.00% 0.97 1.15 -15.65%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 147.85 150.80 169.82 148.39 114.85 90.56 85.12 41.05 38.80 35.69 32.62 Net Sales Growth -7.11% -11.20% 14.44% 29.20% 26.82% 6.39% 107.36% 5.80% 8.71% 9.41% Cost Of Goods Sold 25.10 23.22 35.72 25.77 16.10 15.13 11.05 1.04 2.15 1.48 0.32 Gross Profit 122.75 127.58 134.10 122.61 98.75 75.43 74.07 40.01 36.65 34.21 32.30 GP Margin 83.03% 84.60% 78.97% 82.63% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% 99.02% Total Expenditure 83.62 81.96 91.09 74.76 56.81 50.23 53.29 33.69 32.56 29.64 26.59 Power & Fuel Cost - 26.63 26.53 26.41 21.73 16.57 22.86 20.20 19.33 17.99 17.15 % Of Sales - 17.66% 15.62% 17.80% 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% 52.58% Employee Cost - 11.44 10.21 7.75 7.08 7.11 6.43 5.17 4.46 4.42 4.28 % Of Sales - 7.59% 6.01% 5.22% 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% 13.12% Manufacturing Exp. - 16.02 13.64 10.62 9.00 9.35 10.97 5.67 5.01 4.43 3.58 % Of Sales - 10.62% 8.03% 7.16% 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% 10.97% General & Admin Exp. - 1.91 4.02 2.53 1.43 1.16 0.93 0.95 0.95 0.76 0.77 % Of Sales - 1.27% 2.37% 1.70% 1.25% 1.28% 1.09% 2.31% 2.45% 2.13% 2.36% Selling & Distn. Exp. - 0.27 0.42 1.04 0.31 0.38 0.54 0.32 0.03 0.03 0.00 % Of Sales - 0.18% 0.25% 0.70% 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% 0% Miscellaneous Exp. - 2.46 0.53 0.64 1.15 0.53 0.49 0.35 0.64 0.53 0.00 % Of Sales - 1.63% 0.31% 0.43% 1.00% 0.59% 0.58% 0.85% 1.65% 1.49% 1.50% EBITDA 64.22 68.84 78.73 73.63 58.04 40.33 31.83 7.36 6.24 6.05 6.03 EBITDA Margin 43.44% 45.65% 46.36% 49.62% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% 18.49% Other Income 2.18 2.43 4.37 6.59 4.05 3.27 1.70 2.21 0.17 0.36 0.17 Interest 0.33 0.36 0.23 0.18 0.83 0.98 0.92 0.16 0.42 0.41 0.38 Depreciation 6.26 5.37 3.54 2.58 2.23 1.73 1.36 1.22 1.15 1.12 1.20 PBT 59.80 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 Tax 15.21 16.77 20.17 19.50 15.41 10.70 7.58 1.79 0.97 0.51 0.00 Tax Rate 25.43% 25.59% 25.43% 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% 0.00% PAT 44.60 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 PAT before Minority Interest 44.60 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.17% 32.34% 34.84% 39.07% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% 14.19% PAT Growth -18.43% -17.56% 2.05% 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% -5.40% EPS 4.09 4.47 5.43 5.32 4.00 2.77 2.17 0.59 0.36 0.40 0.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 248.38 201.38 149.15 103.32 69.95 42.20 18.52 12.11 8.21 3.84 Share Capital 10.90 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 237.49 194.11 141.88 96.06 62.68 34.93 11.26 4.85 0.95 -3.42 Non-Current Liabilities 32.37 3.58 1.90 2.02 2.49 4.54 1.43 0.46 1.32 1.52 Secured Loans 29.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 1.05 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 3.18 0.00 0.00 0.40 0.00 Long Term Provisions 0.77 0.69 0.60 0.58 0.51 0.49 0.51 0.46 0.55 0.47 Current Liabilities 37.26 36.20 35.70 31.67 25.87 24.29 12.81 7.92 11.90 9.32 Trade Payables 14.65 9.91 9.54 6.62 3.54 7.45 5.60 5.58 7.14 5.51 Other Current Liabilities 5.63 5.94 4.94 8.60 10.87 9.16 7.13 2.28 3.56 3.63 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 1.14 0.10 Short Term Provisions 16.98 20.35 21.22 16.45 11.46 7.69 0.08 0.06 0.06 0.08 Total Liabilities 318.01 241.16 186.75 137.01 98.31 71.03 32.76 20.49 21.43 14.68 Net Block 41.29 38.02 32.66 19.43 18.95 17.08 14.61 10.59 10.63 9.37 Gross Block 59.33 51.21 44.04 28.24 25.52 21.93 18.10 12.86 11.75 41.61 Accumulated Depreciation 18.04 13.19 11.38 8.81 6.57 4.85 3.49 2.27 1.12 32.24 Non Current Assets 249.34 173.55 104.60 44.11 24.94 34.94 24.72 12.65 13.18 11.47 Capital Work in Progress 184.41 91.22 20.59 12.70 2.07 0.36 0.95 0.17 0.20 0.04 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 Long Term Loans & Adv. 22.26 9.92 9.81 2.77 2.61 2.38 2.45 1.62 2.08 1.74 Other Non Current Assets 1.39 34.39 41.53 9.21 1.31 15.12 6.71 0.27 0.27 0.32 Current Assets 68.67 67.60 82.15 92.90 73.37 36.08 8.04 7.84 8.25 3.21 Current Investments 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 Inventories 5.05 3.33 14.62 11.61 6.05 6.03 0.34 0.46 0.51 0.42 Sundry Debtors 31.24 27.03 17.91 25.12 14.71 20.23 5.80 2.72 6.99 2.16 Cash & Bank 12.55 8.16 9.33 12.35 27.64 2.08 1.70 4.46 0.41 0.19 Other Current Assets 19.84 0.93 1.37 1.76 24.96 7.74 0.20 0.20 0.35 0.44 Short Term Loans & Adv. 19.47 28.16 38.93 42.06 22.98 7.44 0.05 0.06 0.21 0.32 Net Current Assets 31.41 31.40 46.45 61.23 47.50 11.80 -4.77 -0.08 -3.65 -6.11 Total Assets 318.01 241.15 186.75 137.01 98.31 71.02 32.76 20.49 21.43 14.68

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 91.03 64.21 39.48 40.31 10.53 0.63 0.69 5.59 2.80 3.91 PBT 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 Adjustment 5.09 0.46 -2.45 0.15 -0.24 0.65 -3.92 1.44 1.48 1.58 Changes in Working Capital 36.88 4.19 -15.11 -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 -1.70 Cash after chg. in Working capital 107.51 83.99 59.90 54.83 20.66 7.60 1.83 6.17 3.43 4.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.49 -19.78 -20.42 -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 -0.52 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 Cash From Investing Activity -111.82 -55.21 -20.41 -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 -0.78 Net Fixed Assets -101.31 -77.80 -23.69 -13.35 -5.30 -3.24 -6.02 -1.08 29.70 -0.86 Net Investments 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 Others -10.51 22.59 3.28 -16.48 3.04 0.26 0.27 0.05 -32.21 0.08 Cash from Financing Activity 26.01 -8.59 -13.27 -14.00 -5.16 2.10 5.29 -3.80 -0.19 -3.15 Net Cash Inflow / Outflow 5.22 0.41 5.79 -3.51 3.12 -0.26 0.23 0.76 0.10 -0.01 Opening Cash & Equivalents 6.47 6.05 0.26 3.97 0.86 1.12 0.89 0.13 0.03 0.04 Closing Cash & Equivalent 11.69 6.47 6.05 0.46 3.97 0.86 1.12 0.89 0.13 0.03

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 22.79 18.48 13.69 14.22 48.14 29.04 12.75 8.34 5.65 2.65 ROA 17.44% 27.65% 35.81% 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% 31.50% ROE 21.69% 33.76% 45.92% 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% 302.71% ROCE 27.48% 45.40% 61.51% 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% 80.38% Fixed Asset Turnover 2.73 3.57 4.11 4.27 3.82 4.25 2.65 3.15 1.34 0.79 Receivable days 70.51 48.29 52.91 63.29 70.42 55.80 37.88 45.67 46.80 25.38 Inventory Days 10.13 19.29 32.26 28.06 24.34 13.65 3.55 4.57 4.73 4.19 Payable days 193.03 99.37 114.42 115.10 132.50 42.12 60.55 72.03 77.99 76.35 Cash Conversion Cycle -112.39 -31.80 -29.25 -23.75 -37.74 27.33 -19.12 -21.79 -26.47 -46.78 Total Debt/Equity 0.12 0.00 0.00 0.00 0.04 0.19 0.32 0.05 0.49 0.86 Interest Cover 181.05 347.14 440.64 72.31 42.66 34.85 52.71 12.59 12.96 13.26

Top Investors:

quant mutual fund - quant manufacturing fund

Annual Reports:

News Update:

Guj. Themis Biosyn - Quarterly Results
1st Aug 2025, 13:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback